Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP), India’s premier not-for-profit enabler organisation in the deep tech innovation space, and Indegene, a digital-first, life sciences commercialisation company which counts 19 of the world’s top 20 biopharma companies among its clientele, have joined hands to help early-stage life sciences startups accelerate technology innovation, product development, and go-to-market.

The multi-year agreement will see Indegene bring in financial assistance, mentorship via highly skilled and specialised experts, and a digital service suite, supporting C-CAMP’s efforts in nurturing at least 5-7 early-stage deep-science startups with a 360-degree ecosystem.

This initiative aligns with Indegene’s philosophy of enabling future-ready healthcare globally. The goal of the partnership is to leverage C-CAMP’s incubation programme to strengthen the life sciences innovation ecosystem in India and help bring new drugs/therapies to market faster.

Signing the Memorandum of Understanding (MoU) at C-CAMP premises, C-CAMP Director-CEO, Dr Taslimarif Saiyed, said, “By partnering with Indegene, we will focus our efforts on further augmenting our incubation support capacity and startup access so that more breakthrough innovations can be given world-class support to reach people and solve real-world challenges.”